div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader042vdocumentinreader042viewer20220307065af3e0737f8b9a5b1e8bbd10html5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: KMBT C754-20140918130414 - University of Virginia · Therapeutic Class Malaria covered for active treatment only— not covered for prophylactic treatment Drugs ARAL EN atovaquoneproguanil src=https:reader042vdocumentinreader042viewer20220307065af3e0737f8b9a5b1e8bbd10html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader042vdocumentinreader042viewer20220307065af3e0737f8b9a5b1e8bbd10html5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: KMBT C754-20140918130414 - University of Virginia · Therapeutic Class Malaria covered for active treatment only— not covered for prophylactic treatment Drugs ARAL EN atovaquoneproguanil src=https:reader042vdocumentinreader042viewer20220307065af3e0737f8b9a5b1e8bbd10html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader042vdocumentinreader042viewer20220307065af3e0737f8b9a5b1e8bbd10html5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: KMBT C754-20140918130414 - University of Virginia · Therapeutic Class Malaria covered for active treatment only— not covered for prophylactic treatment Drugs ARAL EN atovaquoneproguanil src=https:reader042vdocumentinreader042viewer20220307065af3e0737f8b9a5b1e8bbd10html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdiv